Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma [Phase 2]
This is a Phase 2 trial evaluating Velcade (bortezomib) in combination with dexamethasone for multiple myeloma, which has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating an idiotype-pulsed allogeneic dendritic cell vaccine for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients [Phase 1, Phase 2]
A Phase 1/2 safety and efficacy study of Imexon in multiple myeloma has completed, reporting the trial results.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) [Phase 2]
Phase 2 clinical trial evaluating treosulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation, focusing on saf…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating the RAD combination (lenalidomide, doxorubicin, dexamethasone) in relapsed or refractory multiple myeloma h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients [Phase 3]
Phase 3 trial comparing high-dose versus standard-dose melphalan in newly diagnosed multiple myeloma patients has completed enrollment with …
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients [Phase 1, Phase 2]
A Phase 1/2 trial evaluating arsenic trioxide in combination with ascorbic acid and melphalan in patients with multiple myeloma has complete…
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer) [Phase 2]
A Phase 2 clinical trial updates on the efficacy of Velcade (bortezomib) for bone tissue outcomes in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma [Phase 3]
Phase 3 clinical trial evaluating the incidence of febrile episodes during stem cell collection after chemotherapy in multiple myeloma patie…
-
CLINICAL_TRIALS research · 2009-06-01Clinical Trial Update: Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD) [Phase 3]
Phase 3 clinical trial evaluating induction regimens Velcade-Dex versus Velcade-Thalidomide-Dexamethasone (VTD) in newly diagnosed multiple …
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: Serum Free Light Change in Multiple Myeloma
An update on a clinical trial investigating changes in serum free light chains in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2009-05-28Clinical Trial Update: Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma [Phase 2]
This release reports results from a completed Phase 2 trial evaluating dose-reduced allogeneic stem cell transplantation after autologous hi…
-
CLINICAL_TRIALS trial_result · 2009-05-11Clinical Trial Update: Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies [Phase 2]
Phase 2 clinical trial update examining chemotherapy-related anemia in patients with non-myeloid malignancies has been completed.
-
CLINICAL_TRIALS withdrawal · 2009-04-23Clinical Trial Update: Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma [Phase 1]
A Phase I trial evaluating P276-00 for safety and efficacy in subjects with multiple myeloma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
This document reports on a Phase 1/2 clinical trial evaluating Holmium-166 DOTMP chemotherapy combined with peripheral stem cell transplanta…
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients [Phase 3]
A Phase 3 clinical trial evaluating bortezomib-induced peripheral neuropathy in patients with multiple myeloma; the project status is curren…
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma [Phase 3]
Phase 3 trial comparing Skeletal Targeted Radiotherapy (STR) plus melphalan with stem cell transplant versus melphalan alone in multiple mye…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma [Phase 1]
A Phase 1 study reports the repeat-dose pharmacokinetics and pharmacodynamics of bortezomib in patients with relapsed multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2009-03-26Clinical Trial Update: VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma [Phase 3]
Phase 3 trial comparing Velcade/Melphalan/Prednisone versus Melphalan/Prednisone in newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS research · 2009-03-13Clinical Trial Update: Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating a four-drug regimen (bortezomib, cyclophosphamide, dexamethasone, and thalid…
-
CLINICAL_TRIALS trial_result · 2009-02-26Clinical Trial Update: A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma [Phase 2]
A Phase 2 study of Panzem (2-methoxyestradiol) in patients with relapsed or plateau phase multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Phase 3]
This is a Phase 3 trial evaluating combination chemotherapy with or without idarubicin followed by peripheral stem cell transplantation in p…
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma [Phase 3]
A Phase 3 trial (IFM 2005-01) comparing Velcade plus dexamethasone versus Vincristine/Adriamycin/Dexamethasone in patients with multiple mye…
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma [Phase 1]
A Phase 1 trial comparing pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of bortezomib in patients …
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma [Phase 3]
A Phase 3 clinical trial investigating the optimal timing of a second autologous peripheral blood stem cell transplantation in patients unde…